Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice

被引:22
|
作者
Li, Zhenhua [1 ]
Zhang, Yingzhan [2 ]
Liu, Bin [2 ]
Luo, Wenhong [3 ]
Li, Hui [3 ]
Zhou, Yingbi [2 ]
机构
[1] Shantou Univ, Affiliated Hosp 2, Coll Med, Dept Pathol, Shantou, Peoples R China
[2] Shantou Univ, Coll Med, Cardiovasc Res Ctr, Shantou, Peoples R China
[3] Shantou Univ, Coll Med, Cent Lab, Shantou, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
ENDOTHELIUM-DEPENDENT CONTRACTIONS; SMOOTH-MUSCLE; RESISTANCE ARTERIES; HYPERTENSIVE-RATS; ARACHIDONIC-ACID; AORTA; DYSFUNCTION; RELAXATION; I-2; SHR;
D O I
10.1038/srep42167
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostacyclin, also termed as prostaglandin I-2 (PGI(2)), evokes contraction in vessels with limited expression of the prostacyclin receptor. Although the thromboxane-prostanoid receptor (TP) is proposed to mediate such a response of PGI(2), other unknown receptor(s) might also be involved. TP knockout (TP-/-) mice were thus designed and used to test the hypothesis. Vessels, which normally show contraction to PGI(2), were isolated for functional and biochemical analyses. Here, we showed that the contractile response evoked by PGI(2) was indeed only partially abolished in the abdominal aorta of TP-/- mice. Interestingly, further antagonizing the E-type prostaglandin receptor EP3 removed the remaining contractile activity, resulting in relaxation evoked by PGlI in such vessels of TP-/- mice. These results suggest that EP3 along with TP contributes to vasoconstrictor responses evoked by PGI(2), and hence imply a novel mechanism for endothelial cyclooxygenase metabolites (which consist mainly of PGI(2)) in regulating vascular functions.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor
    Juteau, HN
    Gareau, Y
    Labelle, M
    Sturino, CF
    Sawyer, N
    Tremblay, N
    Lamontagne, S
    Carrière, MC
    Denis, D
    Metters, KM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (08) : 1977 - 1984
  • [32] Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP3 prostanoid receptor
    Gallant, M
    Carrière, MC
    Chateauneuf, A
    Denis, D
    Gareau, Y
    Godbout, C
    Greig, G
    Juteau, H
    Lachance, N
    Lacombe, P
    Lamontagne, S
    Metters, KM
    Rochette, C
    Ruel, R
    Slipetz, D
    Sawyer, N
    Tremblay, N
    Labelle, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (18) : 2583 - 2586
  • [33] Prostaglandin E2 EP3 receptor modulation of insulin secretion in diabetes
    Ceddia, Ryan P.
    Gannon, Maureen
    Breyer, Richard M.
    FASEB JOURNAL, 2013, 27
  • [34] Harnessing the antiplatelet effects of prostaglandin E2 by EP3 receptor blockade
    Iyu, D.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 350 - 351
  • [35] Prostaglandin E2 Mediates Cough Via the EP3 Receptor.
    Maher, S. A.
    Birrell, M. A.
    Belvisi, M. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [36] Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis
    Amano, Hideki
    Ito, Yoshiya
    Suzuki, Tastunori
    Kato, Shintaro
    Matsui, Yoshio
    Ogawa, Fumihiro
    Murata, Takahiko
    Sugimoto, Yukihiko
    Senior, Robert
    Kitasato, Hidero
    Hayashi, Izumi
    Satoh, Yukitoshi
    Narumiya, Shuh
    Majima, Masataka
    CANCER SCIENCE, 2009, 100 (12) : 2318 - 2324
  • [37] Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor
    Gu, Xiaosong
    Xu, Jiang
    Zhu, Liping
    Bryson, Timothy
    Yang, Xiao-Ping
    Peterson, Edward
    Harding, Pamela
    CIRCULATION-HEART FAILURE, 2016, 9 (08)
  • [38] Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development
    Shoji, Y
    Takahashi, M
    Kitamura, T
    Watanabe, K
    Kawamori, T
    Maruyama, T
    Sugimoto, Y
    Negishi, M
    Narumiya, S
    Sugimura, T
    Wakabayashi, K
    GUT, 2004, 53 (08) : 1151 - 1158
  • [39] Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor
    Gu, Xiaosong
    Xu, Jiang
    Yang, Xiao-Ping
    Peterson, Edward
    Harding, Pamela
    CIRCULATION RESEARCH, 2015, 117
  • [40] Involvement of prostaglandin E receptor EP3 subtype in duodenal bicarbonate secretion in rats
    Aihara, Eitaro
    Nomura, Yoko
    Sasaki, Yoko
    Ise, Fumitaka
    Kita, Kazutomo
    Takeuchi, Koji
    LIFE SCIENCES, 2007, 80 (26) : 2446 - 2453